Trudy Vanhove has joined regenerative medicine biotech Surrozen as chief medical officer. Vanhove most recently worked at Jazz Pharmaceuticals (NASDAQ: [[ticker:JAZZ]]), where she was vice president of medical affairs as well as vice president of R&D search and evaluation. South San Francisco-based Surrozen is developing drugs that activate and regulate tissue repair in the body.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
